Anavex Life Sciences Corporation (NASDAQ: AVXL) is -20.30% lower on its value in year-to-date trading and has touched a low of $3.25 and a high of $14.44 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AVXL stock was last observed hovering at around $8.02 in the last trading session, with the day’s gains setting it 0.54%.
Currently trading at $8.56, the stock is -6.21% and -4.43% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.23 million and changing 6.73% at the moment leaves the stock 15.31% off its SMA200. AVXL registered 70.52% gain for a year compared to 6-month gain of 50.70%. The firm has a 50-day simple moving average (SMA 50) of $8.9572 and a 200-day simple moving average (SMA200) of $7.42325.
The stock witnessed a 1.78% loss in the last 1 month and extending the period to 3 months gives it a -22.46%, and is -8.55% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.21% over the week and 6.77% over the month.
Anavex Life Sciences Corporation (AVXL) has around 42 employees, a market worth around $728.14M and $0.00M in sales. Fwd P/E is 6.48. Distance from 52-week low is 163.38% and -40.72% from its 52-week high. The company has generated returns on investments over the last 12 months (-41.92%).
The EPS is expected to shrink by -22.44% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
217.0 institutions hold shares in Anavex Life Sciences Corporation (AVXL), with institutional investors hold 36.27% of the company’s shares. The shares outstanding are 84.99M, and float is at 82.26M with Short Float at 29.23%. Institutions hold 35.16% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 6.39 million shares valued at $26.97 million. The investor’s holdings represent 7.5607 of the AVXL Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 4.55 million shares valued at $19.19 million to account for 5.5154 of the shares outstanding. The other top investors are STATE STREET CORP which holds 3.74 million shares representing 4.4246 and valued at over $15.78 million, while GEODE CAPITAL MANAGEMENT, LLC holds 2.1663 of the shares totaling 1.83 million with a market value of $7.73 million.
Anavex Life Sciences Corporation (AVXL) Insider Activity
The most recent transaction is an insider purchase by Donhauser Peter D.O., the company’s Director. SEC filings show that Donhauser Peter D.O. bought 2,835 shares of the company’s common stock on Jun 14 ’24 at a price of $3.64 per share for a total of $10319.0. Following the purchase, the insider now owns 5000.0 shares.
Anavex Life Sciences Corporation disclosed in a document filed with the SEC on May 15 ’24 that Thomas Steffen (Director) bought a total of 5,000 shares of the company’s common stock. The trade occurred on May 15 ’24 and was made at $4.52 per share for $22600.0. Following the transaction, the insider now directly holds 5000.0 shares of the AVXL stock.
